BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19358175)

  • 1. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
    Swärd C; Johanson V; Nieveen van Dijkum E; Jansson S; Nilsson O; Wängberg B; Ahlman H; Kölby L
    Br J Surg; 2009 May; 96(5):517-21. PubMed ID: 19358175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases.
    Kamat PP; Gupta S; Ensor JE; Murthy R; Ahrar K; Madoff DC; Wallace MJ; Hicks ME
    Cardiovasc Intervent Radiol; 2008; 31(2):299-307. PubMed ID: 17922160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
    Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
    Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.
    van der Horst-Schrivers AN; Post WJ; Kema IP; Links TP; Willemse PH; Wymenga AN; de Vries EG
    Eur J Cancer; 2007 Dec; 43(18):2651-7. PubMed ID: 17825550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L; Persson G; Franzén S; Ahrén B
    Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases.
    Ljungberg M; Westberg G; Vikhoff-Baaz B; Starck G; Wängberg B; Ekholm S; Ahlman H; Forssell-Aronsson E
    Acta Radiol; 2012 Dec; 53(10):1118-26. PubMed ID: 23051638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
    Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
    Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors.
    Lunderquist A; Ericsson M; Nobin A; Sandén G
    Radiologe; 1982 Feb; 22(2):65-70. PubMed ID: 7071325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
    Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
    Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.
    Søreide O; Berstad T; Bakka A; Schrumpf E; Hanssen LE; Engh V; Bergan A; Flatmark A
    Surgery; 1992 Jan; 111(1):48-54. PubMed ID: 1728075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
    Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
    Jermendy G; Kónya A; Kárpáti P
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.